These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18849166)

  • 21. Discovery of novel antagonists of human neurotensin receptor 1 on the basis of ligand and protein structure.
    Zhang G; Wang K; Li XD; Zhang DL; Xu F
    Biomed Pharmacother; 2016 Dec; 84():147-157. PubMed ID: 27643557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of highly potent and neurotensin receptor 2 selective neurotensin mimetics.
    Einsiedel J; Held C; Hervet M; Plomer M; Tschammer N; Hübner H; Gmeiner P
    J Med Chem; 2011 Apr; 54(8):2915-23. PubMed ID: 21446649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of N-{[6-chloro-4-(2,6-dimethoxyphenyl)quinazolin-2-yl]carbonyl}-l-leucine (NTRC-808), a novel nonpeptide chemotype selective for the neurotensin receptor type 2.
    Thomas JB; Giddings AM; Olepu S; Wiethe RW; Harris DL; Narayanan S; Warner KR; Sarret P; Longpre JM; Runyon SP; Gilmour BP
    Bioorg Med Chem Lett; 2015 Jan; 25(2):292-6. PubMed ID: 25499438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a robust GABA(B) calcium signaling cell line using beta-lactamase technology and sorting.
    Cui M; Chung FZ; Donahue CJ
    Cytometry A; 2008 Aug; 73(8):761-6. PubMed ID: 18612970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential allosteric modulation within dopamine D
    Plach M; Schäfer T; Borroto-Escuela DO; Weikert D; Gmeiner P; Fuxe K; Friedland K
    Sci Rep; 2019 Nov; 9(1):16312. PubMed ID: 31704949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scoring ligand similarity in structure-based virtual screening.
    Zavodszky MI; Rohatgi A; Van Voorst JR; Yan H; Kuhn LA
    J Mol Recognit; 2009; 22(4):280-92. PubMed ID: 19235177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NTS2-selective neurotensin mimetics with tetrahydrofuran amino acids.
    Simeth NA; Bause M; Dobmeier M; Kling RC; Lachmann D; Hübner H; Einsiedel J; Gmeiner P; König B
    Bioorg Med Chem; 2017 Jan; 25(1):350-359. PubMed ID: 27842797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists.
    Wijtmans M; Celanire S; Snip E; Gillard MR; Gelens E; Collart PP; Venhuis BJ; Christophe B; Hulscher S; van der Goot H; Lebon F; Timmerman H; Bakker RA; Lallemand BI; Leurs R; Talaga PE; de Esch IJ
    J Med Chem; 2008 May; 51(10):2944-53. PubMed ID: 18433114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The amide linker in nonpeptide neurotensin receptor ligands plays a key role in calcium signaling at the neurotensin receptor type 2.
    Thomas JB; Giddings AM; Olepu S; Wiethe RW; Warner KR; Sarret P; Longpre JM; Runyon SP; Gilmour BP
    Bioorg Med Chem Lett; 2015; 25(10):2060-4. PubMed ID: 25881832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of structurally diverse growth hormone secretagogue agonists by virtual screening and structure-activity relationship analysis of 2-formylaminoacetamide derivatives.
    Shoda M; Harada T; Kogami Y; Tsujita R; Akashi H; Kouji H; Stahura FL; Xue L; Bajorath J
    J Med Chem; 2004 Aug; 47(17):4286-90. PubMed ID: 15294000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The discovery of indole full agonists of the neurotensin receptor 1 (NTSR1).
    Di Fruscia P; He Y; Koenig M; Tabrizifard S; Nieto A; McDonald PH; Kamenecka TM
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3974-8. PubMed ID: 24997685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: the discovery of new functionally selective muscarinic agonists.
    Scapecchi S; Nesi M; Matucci R; Bellucci C; Buccioni M; Dei S; Guandalini L; Manetti D; Martini E; Marucci G; Romanelli MN; Teodori E; Cirilli R
    J Med Chem; 2008 Jul; 51(13):3905-12. PubMed ID: 18543900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NTS2 modulates the intracellular distribution and trafficking of NTS1 via heterodimerization.
    Perron A; Sharif N; Sarret P; Stroh T; Beaudet A
    Biochem Biophys Res Commun; 2007 Feb; 353(3):582-90. PubMed ID: 17188644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring the mechanism of agonist efficacy: a relationship between efficacy and agonist dissociation rate at the muscarinic M3 receptor.
    Sykes DA; Dowling MR; Charlton SJ
    Mol Pharmacol; 2009 Sep; 76(3):543-51. PubMed ID: 19498041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions of histamine H1-receptor agonists and antagonists with the human histamine H4-receptor.
    Deml KF; Beermann S; Neumann D; Strasser A; Seifert R
    Mol Pharmacol; 2009 Nov; 76(5):1019-30. PubMed ID: 19720730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a novel transmembrane domain involved in the negative modulation of mGluR1 using a newly discovered allosteric mGluR1 antagonist, 3-cyclohexyl-5-fluoro-6-methyl-7-(2-morpholin-4-ylethoxy)-4H-chromen-4-one.
    Fukuda J; Suzuki G; Kimura T; Nagatomi Y; Ito S; Kawamoto H; Ozaki S; Ohta H
    Neuropharmacology; 2009 Sep; 57(4):438-45. PubMed ID: 19559036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A virtual screening study of the 18 kDa translocator protein using pharmacophore models combined with 3D-QSAR studies.
    Tuccinardi T; Taliani S; Bellandi M; Da Settimo F; Da Pozzo E; Martini C; Martinelli A
    ChemMedChem; 2009 Oct; 4(10):1686-94. PubMed ID: 19688807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of insulin release by adenosine A1 receptor agonists and antagonists in INS-1 cells: the possible contribution of 86Rb+ efflux and 45Ca2+ uptake.
    Töpfer M; Burbiel CE; Müller CE; Knittel J; Verspohl EJ
    Cell Biochem Funct; 2008 Dec; 26(8):833-43. PubMed ID: 18979526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SPR-based fragment screening with neurotensin receptor 1 generates novel small molecule ligands.
    Huber S; Casagrande F; Hug MN; Wang L; Heine P; Kummer L; Plückthun A; Hennig M
    PLoS One; 2017; 12(5):e0175842. PubMed ID: 28510609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Occurrence and pharmacological characterization of four human tachykinin NK2 receptor variants.
    Ahlstedt I; Engberg S; Smith J; Perrey C; Moody A; Morten J; Lagerström-Fermér M; Drmota T; von Mentzer B; Påhlman I; Lindström E
    Biochem Pharmacol; 2008 Aug; 76(4):476-81. PubMed ID: 18601911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.